Search Results | Scholarly Articles, Journals, and E-Books

Results: 6

Risk of Guillain-Barré syndrome after vaccination against human papillomavirus: a systematic review and meta-analysis, 1 January 2000 to 4 April 2020.
Published in:
Eurosurveillance (15607917), 2022, v. 27, n. 4, p. 44, doi. 10.2807/1560-7917.ES.2022.27.4.2001619
By:
- Boender, T. Sonia;
- Bartmeyer, Barbara;
- Coole, Louise;
- Wichmann, Ole;
- Harder, Thomas
Publication type:
Article
Variability in detection of SARS-CoV-2-specific antibody responses following mild infection: a prospective multicentre cross-sectional study, London, United Kingdom, 17 April to 17 July 2020.
Published in:
Eurosurveillance (15607917), 2022, v. 27, n. 4, p. 34, doi. 10.2807/1560-7917.ES.2022.27.4.2002076
By:
- Pallett, Scott J. C.;
- Jones, Rachael;
- Abdulaal, Ahmed;
- Pallett, Mitchell A.;
- Rayment, Michael;
- Patel, Aatish;
- Denny, Sarah J.;
- Mughal, Nabeela;
- Khan, Maryam;
- Rosadas de Oliveira, Carolina;
- Pantelidis, Panagiotis;
- Randell, Paul;
- Toumazou, Christofer;
- O'Shea, Matthew K.;
- Tedder, Richard;
- McClure, Myra O.;
- Davies, Gary W.;
- Moore, Luke S. P.
Publication type:
Article
Is clinical primary care surveillance for tularaemia a useful addition to laboratory surveillance? An analysis of notification data for Finland, 2013 to 2019.
Published in:
Eurosurveillance (15607917), 2022, v. 27, n. 4, p. 27, doi. 10.2807/1560-7917.ES.2022.27.4.2100098
By:
- Hammer, Charlotte C.;
- Dub, Timothee;
- Luomala, Oskari;
- Sane, Jussi
Publication type:
Article
Surveillance of leishmaniasis cases from 15 European centres, 2014 to 2019: a retrospective analysis.
Published in:
Eurosurveillance (15607917), 2022, v. 27, n. 4, p. 16, doi. 10.2807/1560-7917.ES.2022.27.4.2002028
By:
- Van der Auwera, Gert;
- Davidsson, Leigh;
- Buffet, Pierre;
- Ruf, Marie-Thérèse;
- Gramiccia, Marina;
- Varani, Stefania;
- Chicharro, Carmen;
- Bart, Aldert;
- Harms, Gundel;
- Chiodini, Peter L.;
- Brekke, Hanne;
- Robert-Gangneux, Florence;
- Cortes, Sofia;
- Verweij, Jaco J.;
- Scarabello, Alessandra;
- Söbirk, Sara Karlsson;
- Guéry, Romain;
- van Henten, Saskia;
- Di Muccio, Trentina;
- Carra, Elena
Publication type:
Article
Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022.
Published in:
Eurosurveillance (15607917), 2022, v. 27, n. 4, p. 10, doi. 10.2807/1560-7917.ES.2022.27.4.2101196
By:
- Eggink, Dirk;
- Andeweg, Stijn P.;
- Vennema, Harry;
- van Maarseveen, Noortje;
- Vermaas, Klaas;
- Vlaemynck, Boris;
- Schepers, Raf;
- van Gageldonk-Lafeber, Arianne B.;
- van den Hof, Susan;
- Reusken, Chantal B. E. M.;
- Knol, Mirjam J.
Publication type:
Article
Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.
Published in:
Eurosurveillance (15607917), 2022, v. 27, n. 4, p. 2, doi. 10.2807/1560-7917.ES.2022.27.4.2200077
By:
- Veneti, Lamprini;
- Bøås, Håkon;
- Kristoffersen, Anja Bråthen;
- Stålcrantz, Jeanette;
- Bragstad, Karoline;
- Hungnes, Olav;
- Storm, Margrethe Larsdatter;
- Aasand, Nina;
- Rø, Gunnar;
- Starrfelt, Jostein;
- Seppälä, Elina;
- Kvåle, Reidar;
- Vold, Line;
- Nygård, Karin;
- Buanes, Eirik Alnes;
- Whittaker, Robert
Publication type:
Article

Risk of Guillain-Barré syndrome after vaccination against human papillomavirus: a systematic review and meta-analysis, 1 January 2000 to 4 April 2020.

Variability in detection of SARS-CoV-2-specific antibody responses following mild infection: a prospective multicentre cross-sectional study, London, United Kingdom, 17 April to 17 July 2020.

Is clinical primary care surveillance for tularaemia a useful addition to laboratory surveillance? An analysis of notification data for Finland, 2013 to 2019.

Surveillance of leishmaniasis cases from 15 European centres, 2014 to 2019: a retrospective analysis.

Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022.

Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.